Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.

Seminars in oncology - 1 Feb 2013

Strosberg Jonathan R

Abstract excerpt

Pheochromocytomas, paragangliomas, and medullary thyroid carcinomas (MTCs) originate in cells that share a common neuroectodermal origin. Like other neuroendocrine neoplasms, they are characterized by a propensity to secrete amines (epinephrine and norepinephrine) and peptide hormones (calcitonin). Improved understanding of underlying molecular pathways, such as mutations of the RET (rearranged during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Neoplasms
Share to Adrenal Gland Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adrenocortical Carcinoma

Share to Carcinoma, Neuroendocrine

Share to Paraganglioma

Share to Pheochromocytoma

Share to Proto-Oncogene Mas

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 23391119
DOI: 10.1053/j.seminoncol.2012.11.009

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.PMID 23391119Read ↗

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted TherapiesSemantic proximity Read ↗

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task ForceSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of OriginSemantic proximity Read ↗

Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and ImagingSemantic proximity Read ↗

The evolving landscape of neuroendocrine tumors.Semantic proximity Read ↗

Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.Semantic proximity Read ↗

Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic optionsSemantic proximity Read ↗

Perioperative Management of Pheochromocytomas and Sympathetic ParagangliomasSemantic proximity Read ↗

Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic AdvancesSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.